Mammary tumors in GR/A female mice which appear during the reproductive periods are pregnancy-dependent.
Recently, Sluyser et al.(1976) determined the estrogen and progesterone receptor of transplanted mammary tumors in GR/A mice induced by treatment with estrogen and progesterone, and found that the hormone-dependent tumors contained high levels of receptors to both estrogen and progesterone, while the autonomous tumors had low estrogen receptors and were devoid of progesterone receptors.
Our previous paper revealed that promotion by progesterone of DNA synthesis in pregnancy-dependent mammary tumors after parturition was enhanced by human placental lactogen . Placental lactogen of humans (Sakai et al., 1975) as well as of mice (Sakai and Kohmoto, 1976) was found to compete with 125I-labeled ovine prolactin in binding to mouse mammary tissues. Prolactin is the primary hormone for mammary gland and function and its binding to the specific receptor sites is the initial step for manifestation of the effects. Pregnancy-dependent mammary tumors in GR/A mice are considered to be in transition from normal glands to malignant cancers . They are different from normal glands in responsiveness to hormones, while they still partially retain the intrinsic biological characteristics of normal glands Results Fig. 1 shows the displacement of 125I-labeled prolactin with various amounts of native prolactin. The presence of doseresponse displacement indicates the adequacy of this method to pregnancy-dependent mammary tumors as well as to normal mammary glands.
The prolactin binding in normal mammary glands and mammary tumors and plasma prolactin levels are presented in Fig. 2 . On day 19 of pregnancy, prolactin binding was low in both normal glands and tumors.
One day after parturition, prolactin binding of nonlactating mammary glands was as low as that on day 19 of pregnancy.
On the other hand, that of lactating glands was raised significantly (P<0.01).
There was no difference in the binding of tumors between lactating and nonlactating animals 1day after parturition, both being significantly higher than in mice on day 19 of pregnancy (P<0.01), whereas this type of tumors were abruptly regressed after parturition irrespective of lactation.
Plasma prolactin levels in mice on day 19 of pregnancy were significantly higher glands was as low as that on day 19 of pregnancy, while that of lactating glands was raised, accord well with the results in rats (Bohnet et al., 1977) and these would mostly be reasonable from the physiological point of view; the synthesis of milk in mammary lobulo-alveoli, for which prolactin is essential, becomes conspicuous by suckling and is reduced by litter removal. On the other hand, there was no difference in prolactin binding of tumors between lactating and nonlactating animals. The mammary tumors are clearly different from normal glands in prolactin binding as well as in the other characteristics, while the former still retains some characteristics of the latter. They further suggest that the presence of prolactin binding sites may not always predict directly the responsiveness to prolactin of pregnancy-dependent mammary tumors as observed in 7, 12-dimethylbenz [a] anthracene (DMBA)-induced, prolactin dependent mammary tumors in rats (Costlow et al., 1976; D. Sombre et al., 1976; Smith et al., 1976) .
It is reported that prolactin modifies its own receptor in the liver and mammary tumors in rats (Costlow et al., 1975a (Costlow et al., , b, 1976 Holdaway and Friesen, 1976; Posner et al., 1974 and . However, no close relations between plasma prolactin levels and binding seen in the present study would indicate that the change in prolactin levels in the circulation near parturition is not so great as to alter prolactin receptor as suggested previously 
